Русский
Features of the epidemic process of chronic hepatitis B in the Russian Federation and the Samara Region
DOI: https://dx.doi.org/10.18565/epidem.2020.10.2.11-4
Churbakova O.V., Akimkin V.G., Pechkurov D.V.
1) Samara State Medical University, Ministry of Health of Russia, Samara, Russia; 2) Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia
Materials and methods. Analysis was based on the data of official statistics, such as materials of the Federal Service for Supervision of Consumer Rights Protection and Human Well-Being and its Directorate for the Samara Region.
Results. During the period 2002 to 2018, the rate of an increase in the incidence of CHB decreased in both the entire country and the Samara Region. There were positive results of the impact of hepatitis B immunoprophylaxis in the population of the Samara Region. Hepatitis B vaccination in children below the age of 18 years led to the fact that there was no new case of CHB infection among those in the region in the past 3 years.
Literature
1. Полянина А.В., Быстрова Т.Н., Залесских А.А. Оценка популяционного иммунитета к вирусу гепатита В у население крупного города европейской части России. Здоровье населения и среда обитания 2009; 12(329): 62–5. Polyanina A.V., Bystrov T.N., Zalesskikh A.A. [Assessment of population immunity to hepatitis B virus in the population of a large city of the European part of Russia]. Zdorovye naseleniya i sreda obitaniya 2009; 12(329): 62–5. (In Russ.). 2. Высоцкая В.С., Волченко А.Н., Коломиец Н.Д., Романова О.Н., Глинская И. Н. Влияние вакцинации на эпидемический процесс вирусного гепатита В в Республике Беларусь. Эпидемиология и вакцинопрофилактика 2019; 18(1): 26–33. https://doi.org/10.31631/2073-3046-2019-18-1-26-33 Vysotskaya V.S., Volchenko A.N., Kolomyets N.D., Romanova O.N., Glinskaya I.N. [Vaccination Effect on Epidemic Process of Viral Hepatitis B In Republic of Belarus]. Epidemiologiya i vaktsinoprofilaktika2019; 18(1): 26–33. (In Russ.). https://doi.org/10.31631/2073-3046-2019-18-1-26-33 3. О состоянии санитарно-эпидемиологического благополучия населения в Российской Федерации в 2018 году. Государственный доклад. М.: Федеральная служба по надзору в сфере защиты прав потребителей и благополучия человека, 2018. https://rospotrebnadzor.ru/documents/ details.php?ELEMENT_ID=12053[On the State of Sanitary and Epidemiological Well-Being of the Population in the Russian Federation in 2018. State Report]. Moscow, 2018. (In Russ.). https://rospotrebnadzor.ru/documents/details.php?ELEMENT_ ID=12053 4. Шапиева Н.Т., Понежева Ж.Б., Макашова В.В., Омарова Х.Г. Современные аспекты хронического гепатита В. Лечащий врач 2019; (5): 82–7. Shapieva N.T., Ponezheva Zh.B., Makashova V.V., Omarova H.G. [Modern aspects of chronic hepatitis V]. Lechashchiy vrach 2019; (5): 82–7. (In Russ.). 5. Калинина З.П., Дарьина М.Г., Мовчан К.Н., Мамичева О.Ю., Гагаркина И.Б., Аверина Т.Я., Балабаш О.А., Ефимова Л.И., Потемкина И.В. О поствакцинальном иммунитете против вирусного гепатита В у медицинских работников Санкт-Петербурга. Инфекция и иммунитет 2015; 5(1): 89–92. https://www.lvrach.ru/2019/05/15437301/ Kalinina Z.P., Dar’ina, M.G., Movchan K.N., Mamicheva O. Yu., Gagarkina I.B., Averina T.Ya., Balabash O.A., Efimova L.I., Potemkina I.V. [Duration of postvaccinal immunity against hepatitis B in health care workers in St. Petersburg]. Infektsiya i immunitet 2015; 5(1): 89–92. (In Russ.). https://www.lvrach.ru/2019/05/15437301/ 6. Михайлов М.И., Кюрегян К.К., Малинникова Е.Ю., Исаева О.В. Карлсен А.А., Потемкин И.А., Кичатова В.С., Аль-Шараби Шукри А. C., Догадов Д.И., Корзая Л.И., Игнатьева М.Е, Поляков А. Д. Вирусные гепатиты: прогнозы и проблемы. Эпидемиол. инфекц. болезни. Актуал. вопр. 2019; 9(1): 71–80. https://dx.doi.org/10.18565/epidem.2019.9.1.71-80 Mikhailov M.I., Kyuregyan K.K., Malinnikova E.Yu., Isaeva O.V., Karlsen A.A., Potemkin I.А., Kichatova V.S., Al-Sharabi Shukri A.S., Dogadov D.I., Korzaya L.I., Ignatieva M.E., Polyakov A.D. [Viral hepatitis: prognosis and problems]. Èpidemiologiâ i infekcionnye bolezni. Аktual’nye voprosy 2019; 9(1): 71–80. (In Russ.). DOI: https://dx.doi.org/10.18565/epidem. 2019.9.1.71-80
About the Autors
Information about authors:
Olga V. Churbakovа, Assistant, Department of Health Care Quality Management, Institute of Professional Education, Samara State Medical University, Samara, Russia; е-mail: o_churbakova@mail.ru; ORCID: http://orcid.org/ 0000-0003-3723-1542
Prof. Vasiliy G. Akimkin, MD, Аcademician of the Russian Academy of Sciences, Director, Central Research Institute of Epidemiology, Russian Federal Service for Supervision of Consumer Rights Protection and Human Well-Being, Moscow, Russia; e-mail: vgakimkin@yandex.ru; ОRCID: http://orcid.org/0000-0003-4228-9044
Prof. Dmitry V. Pechkurov, MD, Head, Department of Children’s Diseases, Samara State Medical University, Samara, Russia; е-mail: dmpechkurov@yandex.ru; ОRCID: http://orcid.org/0000-0002-5869-2893
Similar Articles
